Clinical uses and abuses of vitamin E in children

M Mino1

  • 1Department of Pediatrics, Osaka Medical College, Takatsuki, Japan.

Insights

High-dose vitamin E effectively treats deficiencies and related symptoms. However, infant studies show conflicting results and potential risks, possibly due to additives, not vitamin E itself.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Clinical Nutrition

Background:

  • Vitamin E deficiency can cause serious health issues, including spinocerebellar symptoms and anemia in premature infants.
  • Elevated vitamin E dosages are used to manage deficiency symptoms and prevent infant complications like bronchopulmonary dysplasia.
  • Previous studies on vitamin E in infants have yielded conflicting results and raised safety concerns.

Purpose of the Study:

  • To review the benefits of vitamin E in treating deficiencies and associated symptoms.
  • To examine the conflicting results and safety concerns regarding high-dose vitamin E in premature infants.
  • To explore vitamin E's potential role as an antioxidant in inhibiting leukocyte superoxide anion generation.

Main Methods:

  • Literature review of vitamin E benefits and deficiency treatments.
  • Analysis of studies on vitamin E administration in premature infants.
  • Discussion of the potential antioxidant mechanisms of vitamin E.

Main Results:

  • Vitamin E effectively alleviates symptoms of abetalipoproteinemia, chronic cholestasis, and isolated vitamin E deficiency.
  • Conflicting outcomes and unexpected infant deaths have been reported with vitamin E supplementation in premature infants.
  • Safety concerns are often linked to polysorbates in intravenous vitamin E preparations, not vitamin E itself.

Conclusions:

  • Vitamin E is crucial for treating specific deficiencies and preventing certain spinocerebellar symptoms.
  • The use of vitamin E in premature infants requires careful consideration due to inconsistent results and potential risks.
  • Further research is needed to clarify vitamin E's antioxidant functions and optimize its therapeutic application.

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...